169 related articles for article (PubMed ID: 37304482)
1. Profile and Predictors of Infection Following Anti-thymocyte Globulin or Anti-lymphocyte Globulin with Cyclosporine in Aplastic Anemia.
Lionel SA; Selvarajan S; Korula A; Kulkarni U; Devasia A; Abubacker FN; Abraham A; Mathews V; Lakshmi KM; George B
Indian J Hematol Blood Transfus; 2023 Jul; 39(3):419-428. PubMed ID: 37304482
[TBL] [Abstract][Full Text] [Related]
2. Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre.
Shen Y; Li Y; Liu Q; Liu W; Yu Q; Hu H; Liu S; Dong J; Xu M; Hong Y; Chen Y; Deng S; Zhuang H; Hu Z; Lin S; Shen Y; Shen J; Zhou Y; Ye B; Wu D
Ann Med; 2023; 55(2):2271475. PubMed ID: 37871262
[TBL] [Abstract][Full Text] [Related]
3. [Immunosupressive therapy of aplastic anemia patients: successes and failures (single center experiment 2007-2016)].
Mikhaylova EA; Fidarova ZT; Abramova AV; Luchkin AV; Troitskaya VV; Dvirnyk VN; Galtseva IV; Kliasova GA; Kovrigina AM; Kulikov SM; Chabaeva YА; Parovichnikova EN; Savchenko VG; Obukhova TN
Ter Arkh; 2020 Sep; 92(7):4-9. PubMed ID: 33346440
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of two types of antithymocyte globulin in the treatment of children with aplastic anemia].
Xie XT; He W; Shi W; Zhou XX; Qiao XH
Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):294-8. PubMed ID: 27055431
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic efficacy evaluation of rabbit anti-thymocyte globulin combined with cyclosporine A in children with aplastic anemia].
Fu RT; Xue HM; Xu HG; Huang K; Fang JP; Huang SL; Chen C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):426-30. PubMed ID: 23628047
[TBL] [Abstract][Full Text] [Related]
6. Response To Immunosuppressive Therapy In Patients Of Acquired Aplastic Anaemia: A Single Center Experience From A Developing Country.
Khan M; Iftikhar R; Chaudhry QU; Mehmood SK; Faraz T; Ghafoor T; Shahbaz N; Khan MA; Shamshad GU; Khattak TA
J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S969-S973. PubMed ID: 36550655
[TBL] [Abstract][Full Text] [Related]
7. Eltrombopag in Combination with Rabbit Anti-thymocyte Globulin/Cyclosporine A in Immunosuppressive Therapy-naïve Patients with Aplastic Anemia in Japan.
Imada K; Obara N; Iida H; Imajo K; Maeda T; Usuki K; Fanghong Z; Hombo Y; Tajima T; Kumagai A; Matsuda A; Nakao S
Intern Med; 2021 Apr; 60(8):1159-1168. PubMed ID: 33229810
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens.
Zheng Y; Liu Y; Chu Y
Exp Hematol; 2006 Jul; 34(7):826-31. PubMed ID: 16797409
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of immunosuppressive therapy for severe aplastic anemia patients with absolute neutrophil count of zero.
Liu J; Lu XY; Cheng L; Yang Y; Lin SY; Yin H; Liu XQ; Wu XM; He GS
Hematology; 2019 Dec; 24(1):492-497. PubMed ID: 31221029
[No Abstract] [Full Text] [Related]
10. [Treatment outcomes of 125 children with aplastic anemia].
Luo CJ; Chen J; Xue HL; Tang JY; Pan C; Jiang H; Dong L; Luo CY; Ye QD; Zhou M; Gu LJ
Zhonghua Xue Ye Xue Za Zhi; 2010 Aug; 31(8):531-5. PubMed ID: 21122332
[TBL] [Abstract][Full Text] [Related]
11. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.
Chang MH; Kim KH; Kim HS; Jun HJ; Kim DH; Jang JH; Kim K; Jung CW
Eur J Haematol; 2010 Feb; 84(2):154-9. PubMed ID: 19912311
[TBL] [Abstract][Full Text] [Related]
12. Not all anti-T lymphocyte globulin preparations are suitable for use in aplastic anemia: significantly inferior results with jurkat cell-reactive anti-T lymphocyte globulin in clinical practice.
Eylem E; Yahya B; Ozlen B; Umit M; Gursel G; Ayse I; Haluk D; Salih A; Hakan G; Nilgun S; Ibrahim H; Osman O
Int J Clin Exp Med; 2015; 8(9):16334-9. PubMed ID: 26629153
[TBL] [Abstract][Full Text] [Related]
13. Modified immunosuppressive therapy with porcine antilymphocyte globulin plus delayed cyclosporine A in children with severe aplastic anemia.
Cui Q; Sha P; Chen H; Shen H; Qin L; Li Z; Wu T; Wang Z
Int J Hematol; 2018 Jan; 107(1):64-68. PubMed ID: 28900860
[TBL] [Abstract][Full Text] [Related]
14. Relationship between plasma rabbit anti-thymocyte globulin concentration and immunosuppressive therapy response in patients with severe aplastic anemia.
Narita A; Muramatsu H; Ichikawa D; Hamada M; Nishikawa E; Suzuki K; Kawashima N; Okuno Y; Nishio N; Hama A; Yamazaki H; Nakao S; Kojima S; Takahashi Y
Eur J Haematol; 2021 Aug; 107(2):255-264. PubMed ID: 33949001
[TBL] [Abstract][Full Text] [Related]
15. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in severe aplastic anemia patients: A cohort study.
Luo X; Lu H; Xiu B; Wu H; Li B; Li P; Chen Y; Zhou L; Zhang W; Dong Y; Liang A; Ding Y
Exp Ther Med; 2018 Feb; 15(2):1966-1974. PubMed ID: 29434791
[TBL] [Abstract][Full Text] [Related]
17. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
[TBL] [Abstract][Full Text] [Related]
18. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
Zhang X; Li Z; Geng W; Song B; Wan C
Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study.
Liu Q; Dong H; Li Y; Shen Y; Hong Y; Chen Y; Liu S; Wu X; Liu W; Hu H; Zhao Y; Lin S; Shen Y; Zhou Y; Ye B; Wu D
Lipids Health Dis; 2022 Oct; 21(1):93. PubMed ID: 36192750
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcome of Acquired Post-Immunosuppressive-Therapy Aplastic Anemia in Pediatric Patients: A 13-Year Experience in Two Southern China Tertiary Care Centers.
Huang J; Huang L; Liu S; Lin S; Cheng Y; Jiang X; Xue H; Li C; Chen C
Int J Gen Med; 2021; 14():3133-3144. PubMed ID: 34239322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
